The Case Against the SSC

I would like to lay out the scientific case against the Superconducting Supercollider because I think many of my colleagues who understand this case are hesitant to make it, not least because some of the arguments are two-edged. I am very hesitant myself, because I am not against the project, except insofar as it competes for resources which I see as needed more elsewhere. Let me organize my thoughts in terms of four slogans, each of which is aimed at sowing doubt about one of the myths supporti

Written byPhilip Anderson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Let me organize my thoughts in terms of four slogans, each of which is aimed at sowing doubt about one of the myths supporting the unique value of elementary particle physics.

1. The first slide in many general talks given by my colleagues in high-energy physics is a length scale spreading from the "Planck length" (way below elementary particle size) to the size of the cosmos. They gesture deprecatingly toward the center of this scale (where we and our atoms and all of everyday life sit) and say, "Of course, we know everything there, and the only fundamental science is at extreme scales." Well, we don't know everything there. We haven't the foggiest idea what drives the new high-temperature superconductors, or what makes a snowflake, or how the mind or the economy works. What is more, nothing high energy physics can do will ever be of the slightest direct help ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies